{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:44:29Z","timestamp":1764906269227,"version":"3.44.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41440-025-02230-y","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T03:05:01Z","timestamp":1747969501000},"page":"2197-2208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indirect effect of the\u00a0COVID-19 pandemic on cardiovascular diseases incidence, mortality, and healthcare use among patients with hypertension but without SARS-CoV-2 infection in Hong Kong: an interrupted time series analysis"],"prefix":"10.1038","volume":"48","author":[{"given":"Zhuoran","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk Kam","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Ann","family":"Gr\u00e9pin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy Lynn","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary Kui Kai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Vai Kiong","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Welchie Wai Kit","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chak Sing","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Lo Kuen","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2230_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"2230_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052\u20139.","journal-title":"JAMA"},{"key":"2230_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1470320320926899","volume":"21","author":"R Pranata","year":"2020","unstructured":"Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21:1470320320926899.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2230_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882000117X","volume":"148","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect. 2020;148:e106.","journal-title":"Epidemiol Infect"},{"key":"2230_CR5","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"K Whelton Paul","year":"2018","unstructured":"Whelton Paul K, Carey Robert M, Aronow Wilbert S, Casey Donald E, Collins Karen J, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71:e127\u2013e248.","journal-title":"J Am Coll Cardiol"},{"key":"2230_CR6","unstructured":"Lam CL, Ngai K, Lee JP. The Hong Kong Reference Framework for Hypertension Care for adults in primary care settings-translating evidence into practice. Hong Kong Practitioner. 2012;34:76\u201383."},{"key":"2230_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.genhosppsych.2023.01.013","volume":"81","author":"KK Anderson","year":"2023","unstructured":"Anderson KK, Maresh S, Ward A, Koller EA, Connor P, Evans M, et al. The COVID-19 pandemic\u2019s impact on all-cause mortality disparities in Medicare: by race, income, chronic health, mental\/behavioral health, disability. Gen Hosp Psychiatry. 2023;81:57\u201367.","journal-title":"Gen Hosp Psychiatry"},{"key":"2230_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2459\/JCM.0000000000001465","volume":"24","author":"C Hennecken","year":"2023","unstructured":"Hennecken C, Doulamis IP, McLaughlin L, Avgerinos D, Briasoulis A, Kampaktsis PN. Increase in hypertension-related cardiovascular mortality in the United States early in the COVID-19 pandemic. J Cardiovasc Med. 2023;24:315\u20136.","journal-title":"J Cardiovasc Med"},{"key":"2230_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jinf.2020.08.037","volume":"81","author":"S de Lusignan","year":"2020","unstructured":"de Lusignan S, Joy M, Oke J, McGagh D, Nicholson B, Sheppard J, et al. Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network. J Infect. 2020;81:785\u201392.","journal-title":"J Infect"},{"key":"2230_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10771-3","volume":"21","author":"L Li","year":"2021","unstructured":"Li L, Hang D, Dong H, Yuan-Yuan C, Bo-Heng L, Ze-Lin Y, et al. Temporal dynamic in the impact of COVID-19 outbreak on cause-specific mortality in Guangzhou, China. BMC Public Health. 2021;21:883.","journal-title":"BMC Public Health"},{"key":"2230_CR11","unstructured":"COVID-19. https:\/\/www.news.gov.hk\/eng\/categories\/covid19\/index.html. Accessed Jan 18, 2024."},{"key":"2230_CR12","unstructured":"Together, we fight the Virus. https:\/\/www.coronavirus.gov.hk\/eng\/index.html. Accessed Jan 18, 2024."},{"key":"2230_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1473-3099(22)00167-0","volume":"22","author":"T Burki","year":"2022","unstructured":"Burki T. Hong Kong\u2019s fifth COVID-19 wave-the worst yet. Lancet Infect Dis. 2022;22:455\u20136.","journal-title":"Lancet Infect Dis"},{"key":"2230_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4000\/chinaperspectives.7118","volume":"2016","author":"V Schoeb","year":"2016","unstructured":"Schoeb V. Healthcare service in Hong Kong and its challenges. The role of health professionals within a social model of health. China Perspect. 2016;2016:51\u20138.","journal-title":"China Perspect"},{"key":"2230_CR15","unstructured":"Your Health, Your Life: Appendix B Hong Kong\u2019s current healthcare system. Health Bureau; 2013. https:\/\/www.healthbureau.gov.hk\/beStrong\/files\/consultation\/appendixb_eng.pdf."},{"key":"2230_CR16","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehab325","volume":"42","author":"QW Ren","year":"2021","unstructured":"Ren QW, Yu SY, Teng TK, Li X, Cheung KS, Wu MZ, et al. Statin associated lower cancer risk and related mortality in patients with heart failure. Eur Heart J. 2021;42:3049\u201359.","journal-title":"Eur Heart J"},{"key":"2230_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101999","volume":"60","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xu W, Mak IL, Chin WY, Yu EYT, Lam CLK, et al. Trends of clinical parameters and incidences of diabetes mellitus complications among patients with type 2 diabetes mellitus in Hong Kong, 2010-2019: a retrospective cohort study. EClinicalMedicine. 2023;60:101999.","journal-title":"EClinicalMedicine"},{"key":"2230_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028496","volume":"12","author":"SM Kim","year":"2023","unstructured":"Kim SM, Jeong Y, Kim YL, Kang M, Kang E, Ryu H, et al. Association of chronic kidney disease with atrial fibrillation in the general adult population: a nationwide population-based study. J Am Heart Assoc. 2023;12:e028496.","journal-title":"J Am Heart Assoc"},{"key":"2230_CR19","unstructured":"Hong Kong Hospital Authority Quality and Safety Annual Report 2022. https:\/\/www.ha.org.hk\/haho\/ho\/psrm\/E_AnnualReport2022.pdf. Accessed Jan 18, 2024."},{"key":"2230_CR20","volume":"30","author":"H Xin","year":"2023","unstructured":"Xin H, Wu P, Wong JY, Cheung JK, Lau EHY, Leung GM, et al. Hospitalizations and mortality during the first year of the COVID-19 pandemic in Hong Kong, China: an observational study. Lancet Reg Health West Pac. 2023;30:100645.","journal-title":"Lancet Reg Health West Pac"},{"key":"2230_CR21","first-page":"64","volume":"25","author":"MK Lim","year":"2019","unstructured":"Lim MK, Ha SCN, Luk KH, Yip WK, Tsang CSH, Wong MCS. Update on the Hong Kong reference framework for hypertension care for adults in primary care settings-review of evidence on the definition of high blood pressure and goal of therapy. Hong Kong Med J. 2019;25:64\u20137.","journal-title":"Hong Kong Med J"},{"key":"2230_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1213\/ANE.0000000000004153","volume":"129","author":"EJ Mascha","year":"2019","unstructured":"Mascha EJ, Sessler DI. Segmented regression and difference-in-difference methods: assessing the impact of systemic changes in health care. Anesth Analg. 2019;129:618\u201333.","journal-title":"Anesth Analg"},{"key":"2230_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1748-5908-9-77","volume":"9","author":"M Taljaard","year":"2014","unstructured":"Taljaard M, McKenzie JE, Ramsay CR, Grimshaw JM. The use of segmented regression in analysing interrupted time series studies: an example in pre-hospital ambulance care. Implement Sci. 2014;9:77.","journal-title":"Implement Sci"},{"key":"2230_CR24","doi-asserted-by":"publisher","first-page":"8235","DOI":"10.3390\/su14148235","volume":"14","author":"SSS Lau","year":"2022","unstructured":"Lau SSS, Ho CCY, Pang RCK, Su S, Kwok H, Fung S-f, et al. COVID-19 burnout subject to the dynamic zero-COVID policy in Hong Kong: development and psychometric evaluation of the COVID-19 burnout frequency scale. Sustainability. 2022;14:8235.","journal-title":"Sustainability"},{"key":"2230_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","volume":"81","author":"X Li","year":"2022","unstructured":"Li X, Tong X, Yeung WWY, Kuan P, Yum SHH, Chui CSL, et al. Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis. 2022;81:564\u20138.","journal-title":"Ann Rheum Dis"},{"key":"2230_CR26","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3201\/eid2809.220613","volume":"28","author":"YM Mefsin","year":"2022","unstructured":"Mefsin YM, Chen D, Bond HS, Lin Y, Cheung JK, Wong JY, et al. Epidemiology of infections with SARS-CoV-2 omicron BA.2 variant, Hong Kong, January-March 2022. Emerg Infect Dis. 2022;28:1856\u20138.","journal-title":"Emerg Infect Dis"},{"key":"2230_CR27","doi-asserted-by":"crossref","unstructured":"Yang B, Lin Y, Xiong W, Liu C, Gao H, Ho F, et al. Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study. Lancet Regional Health Western Pacific. 2024;43:100969.","DOI":"10.1016\/j.lanwpc.2023.100969"},{"key":"2230_CR28","doi-asserted-by":"crossref","unstructured":"Newey WK, West KD. A simple, positive semi-definite, heteroskedasticity and autocorrelationconsistent covariance matrix. Econometrica. 1986;55:703\u20138.","DOI":"10.2307\/1913610"},{"key":"2230_CR29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245\u201351.","journal-title":"J Clin Epidemiol"},{"key":"2230_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1631\/jzus.B1300109","volume":"15","author":"YQ Huang","year":"2014","unstructured":"Huang YQ, Gou R, Diao YS, Yin QH, Fan WX, Liang YP, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15:58\u201366.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2230_CR31","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.jaccas.2020.04.010","volume":"2","author":"F Moroni","year":"2020","unstructured":"Moroni F, Gramegna M, Ajello S, Beneduce A, Baldetti L, Vilca LM, et al. Collateral damage: medical care avoidance behavior among patients with myocardial infarction during the COVID-19 pandemic. JACC Case Rep. 2020;2:1620\u20134.","journal-title":"JACC Case Rep"},{"key":"2230_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/heartjnl-2020-317912","volume":"107","author":"J Wu","year":"2021","unstructured":"Wu J, Mamas MA, Mohamed MO, Kwok CS, Roebuck C, Humberstone B, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021;107:113\u20139.","journal-title":"Heart"},{"key":"2230_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5334\/aogh.4021","volume":"89","author":"M Fornasini","year":"2023","unstructured":"Fornasini M, Sisa I, Baldeon ME. Increased cardiovascular mortality in ecuador during COVID-19 pandemic. Ann Glob Health. 2023;89:21.","journal-title":"Ann Glob Health"},{"key":"2230_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.15585\/mmwr.mm6925e2","volume":"69","author":"SJ Lange","year":"2020","unstructured":"Lange SJ, Ritchey MD, Goodman AB, Dias T, Twentyman E, Fuld J, et al. Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions - United States, January-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:795\u2013800.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2230_CR35","unstructured":"Department TIS. Hospital services to be adjusted. 2020. https:\/\/www.news.gov.hk\/eng\/2020\/02\/20200210\/20200210_180258_488.html. Accessed 11 June 2024."},{"key":"2230_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pop.2014.02.010","volume":"41","author":"ML Wallace","year":"2014","unstructured":"Wallace ML, Ricco JA, Barrett B. Screening strategies for cardiovascular disease in asymptomatic adults. Prim Care. 2014;41:371\u201397.","journal-title":"Prim Care"},{"key":"2230_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/HJH.0000000000002770","volume":"39","author":"R Kreutz","year":"2021","unstructured":"Kreutz R, Dobrowolski P, Prejbisz A, Algharably EAE, Bilo G, Creutzig F, et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39:1077\u201389.","journal-title":"J Hypertens"},{"key":"2230_CR38","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1161\/HYPERTENSIONAHA.122.19861","volume":"79","author":"H Gotanda","year":"2022","unstructured":"Gotanda H, Liyanage-Don N, Moran AE, Krousel-Wood M, Green JB, Zhang Y, et al. Changes in blood pressure outcomes among hypertensive individuals during the COVID-19 pandemic: a time series analysis in three US healthcare organizations. Hypertension. 2022;79:2733\u201342.","journal-title":"Hypertension"},{"key":"2230_CR39","doi-asserted-by":"publisher","first-page":"e0258015","DOI":"10.1371\/journal.pone.0258015","volume":"16","author":"S Omboni","year":"2021","unstructured":"Omboni S, Ballatore T, Rizzi F, Tomassini F, Panzeri E, Campolo L. Telehealth at scale can improve chronic disease management in the community during a pandemic: an experience at the time of COVID-19. PLoS One. 2021;16:e0258015.","journal-title":"PLoS One"},{"key":"2230_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007098","volume":"14","author":"S Zhang","year":"2021","unstructured":"Zhang S, Zhou X, Chen Y, Wang L, Zhu B, Jiang Y, et al. Changes in home blood pressure monitored among elderly patients with hypertension during the COVID-19 outbreak: a longitudinal study in China leveraging a smartphone-based application. Circ Cardiovasc Qual Outcomes. 2021;14:e007098.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2230_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41440-021-00784-1","volume":"45","author":"F Feitosa","year":"2022","unstructured":"Feitosa F, Feitosa ADM, Paiva AMG, Mota-Gomes MA, Barroso WS, Miranda RD, et al. Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study. Hypertens Res. 2022;45:364\u20138.","journal-title":"Hypertens Res"},{"key":"2230_CR42","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2147\/RMHP.S327644","volume":"14","author":"P Sornsenee","year":"2021","unstructured":"Sornsenee P, Vichitkunakorn P, Choomalee K, Romyasamit C. Effect of the COVID-19 pandemic and other predictors of true therapeutic inertia on patients with hypertension in a primary care clinic in Thailand. Risk Manag Health Policy. 2021;14:3807\u201316.","journal-title":"Risk Manag Health Policy"},{"key":"2230_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27377-2","volume":"8","author":"D Zhou","year":"2018","unstructured":"Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Sci Rep. 2018;8:9418.","journal-title":"Sci Rep"},{"key":"2230_CR44","doi-asserted-by":"crossref","unstructured":"Russo V, Cassini R, Caso V, Donno C, Laezza A, Naddei M, et al. Nursing teleconsultation for the outpatient management of patients with cardiovascular disease during COVID-19 pandemic. Int J Environ Res Public Health. 2021;18:2087.","DOI":"10.3390\/ijerph18042087"},{"key":"2230_CR45","doi-asserted-by":"publisher","first-page":"i2647","DOI":"10.1136\/bmj.i2647","volume":"353","author":"C Salisbury","year":"2016","unstructured":"Salisbury C, O\u2019Cathain A, Thomas C, Edwards L, Gaunt D, Dixon P, et al. Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ. 2016;353:i2647.","journal-title":"BMJ"},{"key":"2230_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2020.575588","volume":"5","author":"HK Ho","year":"2020","unstructured":"Ho HK. COVID-19 pandemic management strategies and outcomes in East Asia and the Western World: the scientific state, democratic ideology, and social behavior. Front Socio. 2020;5:575588.","journal-title":"Front Socio"},{"key":"2230_CR47","unstructured":"Hong Kong Healthcare System and Healthcare Professionals. Hong Kong Health Bureau. 2016. https:\/\/www.healthbureau.gov.hk\/download\/press_and_publications\/otherinfo\/180500_sr\/e_ch1.pdf."},{"key":"2230_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4093\/dmj.2017.41.2.81","volume":"41","author":"IT Lau","year":"2017","unstructured":"Lau IT. A clinical practice guideline to guide a system approach to diabetes care in Hong Kong. Diabetes Metab J. 2017;41:81\u20138.","journal-title":"Diabetes Metab J"},{"key":"2230_CR49","unstructured":"Report of Population Health Survey 2020-22 (Part I). Centre of Health Protection, Department of Health, The Government of Hong Kong SAR. 2022. https:\/\/www.chp.gov.hk\/files\/pdf\/dh_phs_2020-22_part_1_report_eng_rectified.pdf."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02230-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02230-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02230-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:17:30Z","timestamp":1757171850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02230-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02230-y","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EYFW has received research grants from the Health Bureau, the Hong Kong Research Grants Council, Narcotics Division, Security Bureau, Social Welfare Department, Labour and Welfare Bureau of the Government of the Hong Kong SAR and National Natural Science Foundation of China; serves on member of Core Team for Expert Group on Drug Registration of Pharmacy and Poisons Board, and is the director of Advance Data Analytics for Medical Science (ADAMS) Limited (HK). These are outside the submitted work.\u00a0I.C.K.W. received research grants from Amgen, Janssen, GSK, Novartis, Pfizer, Bayer and Bristol-Myers Squibb and Takeda, Institute for Health Research in England, European Commission, National Health and Medical Research Council in Australia, The European Union\u2019s Seventh Framework Programme for research, technological development, Research Grants Council Hong Kong and Health and Medical Research Fund Hong Kong; consulting fees from IQVIA and World Health Organization; payment for expert testimony for Appeal Court in Hong Kong; serves on advisory committees for Member of Pharmacy and Poisons Board; is a member of the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization; is a member of the Advisory Panel on COVID-19 Vaccines of the Hong Kong Government; is the non-executive director of Jacobson Pharma Corp. Ltd. in Hong Kong; and was\u00a0the founder and director of Therakind Limited (UK), currently a director of Advance Data Analytics for Medical Science (ADAMS) Limited (HK) and OCUS Innovation Limited (HK, Ireland and UK).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Severance Hospital Institutional Review Board (IRB No. 4-2022-0248) and the Institutional Review Board of the University of Hong Kong Hospital Authority Hong Kong West Cluster (ref.: UW 21-297).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}